ATRX immunohistochemistry can help refine ‘not elsewhere classified’ categorisation for grade II/III gliomas

Charlotte Burford,Ross Laxton,Z. Sidhu,Miren Aizpurua,Andrew J. King,Istvan Bodi,Keyoumars Ashkan,Safa Al-Sarraj

ATRX immunohistochemistry can help refine ‘not elsewhere classified’ categorisation for grade II/III gliomas

2019

Charlotte Burford
Ross Laxton
Z. Sidhu
Miren Aizpurua
Andrew J. King
Istvan Bodi
Keyoumars Ashkan
Safa Al-Sarraj

AbstractPurpose: The 2016 WHO tumour classification highlights the role of IDH1/2 gene mutation and 1p/19q co-deletion in classifying grade II/III gliomas. A recent cIMPACT-NOW update proposes the ...

Keywords:

ATRX
Pathology
Immunohistochemistry
Medicine
gene mutation
WHO tumour classification
IDH1

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations